Advanced Search
Submit ManuscriptADVANCE ONLINE PUBLICATION
A patient-derived organoid model captures fetal-like plasticity in colorectal cancer
Liang Xiong1,† , Ying Xu1,† , Zhaoya Gao2,3,† , Jingyi Shi4 , Yunfan Wang5 , Xiaodong Wang6 , Wensheng Huang2,3 , Ming Li2,3 , Longteng Wang7 , Jun Xu1 , Cheng Li7 , Jin Gu2,3,4,8,9,* , Hongkui Deng1,* , Molong Qu1,*
1School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center and the MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, ChinaPhenotypic plasticity is a hallmark feature driving cancer progression, metastasis, and therapy resistance. Fetal-like transcriptional programs have been increasingly implicated in promoting plastic cell states, yet their roles remain difficult to study due to limitations of existing culture models. Here, we establish a chemically defined patient-derived organoid system that enables long-term expansion of colorectal cancer (CRC) cells while preserving fetal-like features associated with phenotypic plasticity. Using this model, we identify an oncofetal state (OnFS) that is enriched in advanced tumors and linked to key features of plasticity, including epithelial-mesenchymal plasticity, as well as increased metastasis and treatment resistance. Mechanistically, we show that FGF2-AP-1 signaling maintains the OnFS program and associated phenotypic plasticity in CRC. This model offers a powerful platform for studying the fetal-like features underlying cancer cell plasticity and their role in tumor progression and treatment resistance in CRC.
https://doi.org/10.1038/s41422-025-01139-y